FDA Inspection 1050217 — Community Blood Center Of Greater Kansas City
The FDA completed an inspection of Community Blood Center Of Greater Kansas City on April 6, 2018 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kansas City, MO (United States)